Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. - Wikidata - wikimedia - TriplyDB

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

http://www.wikidata.org/entity/Q37374015

about

Intravascular optical imaging technology for investigating the coronary artery Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples Management of Percutaneous Coronary Intervention Complications.Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound.A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (Xie Intracoronary optical coherence tomography: a comprehensive review clinical and research applications Compensatory Enlargement of Ossabaw Miniature Swine Coronary Arteries in Diffuse Atherosclerosis.Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography.Optical coherence tomography endpoints in stent clinical investigations: strut coverage.New strategies in the treatment of coronary bifurcations.Very Late Stent Thrombosis of Sirolimus-eluting Stent 59 Months After Implantation: A First Report from The Middle-East and Review of Literature.Restenosis after PCI. Part 2: prevention and therapy.Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.Long-term safety of drug-eluting stents.Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction.Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Dextran or Saline Can Replace Contrast for Intravascular Optical Coherence Tomography in Lower Extremity Arteries.Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome.Intravascular ultrasound-guided drug-eluting stent implantation.The comparative safety of bare-metal and drug-eluting intracoronary stents.Coronary aneurysm occurring late after drug-eluting stent implantation Erosion/malapposition of a sirolimus eluting stent - optical coherence tomography image - a case report Automatic stent strut detection in intravascular optical coherence tomographic pullback runs.Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.Combined use of optical coherence tomography and intravascular ultrasound imaging for the evaluation of stent thrombosis.Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.Enlarged coronary artery pseudoaneurysm after drug-eluting stent implantation.A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery.Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.Role of residual acute stent malapposition in percutaneous coronary interventions.Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.

P2860

Q26852822-23822CEB-63DD-4E7B-880E-A113D18895EF Q28068387-6E428231-13F7-4D1E-8064-BF6281B10BCF Q28479223-B56C6E45-21DA-4CB2-875F-B62B2168648A Q30400083-C48C2B5F-574E-49BA-891C-E5BBDBC319B5 Q30415522-AC091C70-353C-4210-85EF-6E1D4125C679 Q33848052-4D8D4D75-810B-42A3-9B0E-D90F251DA8B4 Q33959574-49241DF4-DBA0-4B22-A09C-5A3C1BA12E32 Q35124809-7B831F00-B43D-49B0-BCD4-D58B2A567D34 Q35932110-AFA62187-5A7C-4436-A4A4-C4F2CBD2160A Q36240137-79E5C0FF-BBFD-436C-9A37-7654342FF330 Q37081798-88E21A80-1A7C-4DEC-9805-FE5231255563 Q37330704-5566F3E1-363A-433C-BF1B-76969C007B5F Q37851899-625BC593-92C2-4BC0-BB01-0D00901E57F4 Q37871912-339F371B-BC37-479B-AA20-9439E59A2F5C Q37897983-74DC9EF2-0B8A-4881-B1F0-5F4BD1F71479 Q37944416-56F123B6-80D4-44AC-91F0-E7588C24AEFD Q38010382-E387C5C3-3588-4CD5-B896-359B815132A1 Q38063290-40687488-DEA5-4FE5-A521-AA6240C48FC1 Q38153786-1B62C99C-FAB6-4B11-94D0-D0BC0DA06787 Q38280156-71B8348E-F65A-4321-A285-A348E0945521 Q38381419-B619FA56-D3B1-48B4-98D8-FF567E50141E Q38390456-7A5B201B-A6A1-45FF-A348-0F65F384ED0B Q38699758-17327917-F4B5-46C4-B4C0-29CDA86018BD Q39002367-EB9D20B2-5A46-42CB-9348-EEF85D3A2334 Q39840291-B83C526A-CF46-4583-BE3E-3287935446F3 Q40545273-5B6E672A-8D3E-477B-A78A-2EAF666546E5 Q41829610-1A0AA37B-9AAC-40A9-B950-382885772809 Q42018266-306C33AD-F422-4131-9840-9139A9D415C2 Q42133869-AAF05E26-52D1-482B-BB42-8DE3AA2DF1C4 Q42154709-D0FD11FE-FBF6-4BC0-9807-6AEA63A1E4B0 Q43880648-B6AF86FE-10EC-4F2A-B3D5-17C0DF298C07 Q44079838-BCDE1D70-A2F9-4712-91BD-EF4ECD2C4BB4 Q44262431-A04F4A92-4833-4F71-82B4-5C43AB1753ED Q44672104-F6E2D21C-F182-44DE-8E79-32BED8CB54F6 Q45824729-2240ED0C-B23B-4767-A9EC-1614606846F2 Q45850646-5DF84D10-2245-4E18-ACF5-32C3B1B3BC6D Q47853894-730822A1-7C2F-4B44-8E85-9DA5C27C9829 Q47984223-A2BBD6DE-288E-4214-8C1C-57AE883F1108 Q48122977-E1FA5E99-C6FA-48F3-BE4C-9FFB080227F7 Q50437651-52F0C8D9-0C0D-4099-B31B-E74467EF968A

P2860

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

http://www.wikidata.org/entity/Q37374015

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Late stent malapposition risk ...... es with late stent thrombosis.

@en

Late stent malapposition risk ...... es with late stent thrombosis.

@nl

type

label

Late stent malapposition risk ...... es with late stent thrombosis.

@en

Late stent malapposition risk ...... es with late stent thrombosis.

@nl

prefLabel

Late stent malapposition risk ...... es with late stent thrombosis.

@en

Late stent malapposition risk ...... es with late stent thrombosis.

@nl

P1433

Q37374015-D4B7B489-23BE-44A9-8A9D-A3033B70FFF4

P1476

Q37374015-1E7280F0-FDCC-4616-8DA5-05A31326EB96

P2093

Q37374015-449076B6-E293-487C-91AC-4BC8904E6887

Q37374015-4720EDE3-0AD7-4067-965C-098659563171

Q37374015-932DCC8E-BAF7-402C-9D1D-4B0CE716FB44

Q37374015-970F5AB1-22F8-43A0-ABA5-A144916720C1

Q37374015-C3138894-0BAF-4B2F-93F4-E55A50AEFCE3

Q37374015-E7BC447D-899D-4E38-BE1A-CFC35CABE985

Q37374015-E7D839A9-48B6-4CA6-BD87-95316D996973

Q37374015-EF7F9AE9-E927-4A7F-AC34-D6667094C7D6

P2860

Q37374015-0813741E-5853-4749-A2E0-293648187BA3

Q37374015-1125C447-ABC5-4207-A08D-66026349E344

Q37374015-16D1C271-335F-4115-B138-981F80F8F3DC

Q37374015-3907715F-08FD-46D1-B6E4-4C0D9D3DA379

Q37374015-3B90930B-D900-4239-9809-5042E6CEC45B

Q37374015-42606162-F99C-4184-BF76-2E26775B92F7

Q37374015-45A86008-2F6F-4B85-A3F5-134E255F732A

Q37374015-4AC7CEA8-09C3-4F8F-B4D1-EDF8F9C5B53D

Q37374015-4EF5B150-ED01-4EA6-80A4-C467FD05E552

Q37374015-503C7AF7-951A-47FF-850F-1F7F54A32953

P304

Q37374015-E8F61E8F-D018-4ECC-8F56-37C03A5CEDB2

P31

Q37374015-A515DF64-3546-4AD6-A2F9-872B77AF664B

Q37374015-bc47cd7c-0a48-4cee-adfe-067f11bc9cd8

P356

Q37374015-2FF5C60C-46F0-472E-8DFC-602A79D8BC7C

P433

Q37374015-D2AC38D0-03CA-49FF-85E6-F487736C003E

P478

Q37374015-9F4D69CB-DA8F-4F9E-BB2D-F15A15BDF368

P577

Q37374015-408E34BD-B81A-4A1E-AB6E-D587ECA43650

P5875

Q37374015-4A62B025-9D89-48E3-BDD5-55A1FD2B9C05

P698

Q37374015-634B17AC-EE34-4468-A5CE-C34056F7011B

P921

Q37374015-A33FDEE0-F274-4383-9547-306B0E100A23

P356

P1433

European Heart Journal

P1476

Late stent malapposition risk ...... es with late stent thrombosis.

@en

P2093

Ayman K M Hassan

http://www.w3.org/2001/XMLSchema#string

Bas L van der Hoeven

http://www.w3.org/2001/XMLSchema#string

J Wouter Jukema

http://www.w3.org/2001/XMLSchema#string

Jaapjan D Snoep

http://www.w3.org/2001/XMLSchema#string

Josepha W M Plevier

http://www.w3.org/2001/XMLSchema#string

Martin J Schalij

http://www.w3.org/2001/XMLSchema#string

Sandrin C Bergheanu

http://www.w3.org/2001/XMLSchema#string

Theo Stijnen

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Stent thrombosis in randomized clinical trials of drug-eluting stents

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consen

Advanced methods in meta-analysis: multivariate approach and meta-regression.

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.

The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease.

P304

1172-1180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHN553

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23806791

http://www.w3.org/2001/XMLSchema#string

P698

19158118

http://www.w3.org/2001/XMLSchema#string

P921